Agomab Therapeutics, an Asabys portfolio company, debuts on Nasdaq

by Asabys Partners

The relationship with the company began in 2021, when Agomab acquired Origo Biopharma, one of their portfolio companies, marking Asabys’s first exit. Since then, they have continued to support Agom...

Read more

Agomab Announces $89 Million Series D Financing, with the participation of Asabys, to Support Broad Fibrosis-focused Pipeline

by Asabys Partners

Agomab Therapeutics has announced a $89 million Series D financing round, with participation from new investors Sanofi and Invus, as well as existing investors, including Asabys Partners.

Read more

Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114M

by Asabys Partners

Agomab Therapeutics NV (‘Agomab’) has announced it has extended its Series B financing round with an additional close of $40.5 million (€38.4 million), bringing the total Series B amount raised ...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Xcalibur Smart Mapping strengthens its g...

by MCH Private Equity

​Xcalibur Smart Mapping, recognised as the global leader in airborne...

Photos Stream